Kazutoshi Komiya

728 total citations
39 papers, 575 citations indexed

About

Kazutoshi Komiya is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Kazutoshi Komiya has authored 39 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Kazutoshi Komiya's work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (11 papers) and Cancer Genomics and Diagnostics (9 papers). Kazutoshi Komiya is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (11 papers) and Cancer Genomics and Diagnostics (9 papers). Kazutoshi Komiya collaborates with scholars based in Japan. Kazutoshi Komiya's co-authors include Naoko Sueoka‐Aragane, Shinya Kimura, Tomomi Nakamura, Akemi Sato, Eisaburo Sueoka, Koichiro Takahashi, Chiho Nakashima, Mitsuharu Hirai, Shinichiro Hayashi and Kentaro Iwanaga and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kazutoshi Komiya

39 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazutoshi Komiya Japan 14 305 265 184 183 45 39 575
Moon Young Choi South Korea 11 283 0.9× 238 0.9× 165 0.9× 70 0.4× 51 1.1× 44 585
Ming Ouyang China 11 154 0.5× 156 0.6× 99 0.5× 100 0.5× 32 0.7× 28 337
Joonho Shim South Korea 17 279 0.9× 300 1.1× 179 1.0× 185 1.0× 84 1.9× 58 800
Thomas Boulet France 17 127 0.4× 352 1.3× 206 1.1× 220 1.2× 58 1.3× 36 686
Shaohong Huang China 12 114 0.4× 183 0.7× 237 1.3× 189 1.0× 29 0.6× 34 500
Andrew A. Davis United States 10 174 0.6× 346 1.3× 109 0.6× 163 0.9× 35 0.8× 23 494
Xia Zhu China 8 254 0.8× 278 1.0× 287 1.6× 171 0.9× 49 1.1× 14 632
Yingjie Wang China 12 388 1.3× 117 0.4× 124 0.7× 94 0.5× 47 1.0× 60 727
Yoshiaki Nagai Japan 11 720 2.4× 622 2.3× 262 1.4× 249 1.4× 42 0.9× 39 979

Countries citing papers authored by Kazutoshi Komiya

Since Specialization
Citations

This map shows the geographic impact of Kazutoshi Komiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazutoshi Komiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazutoshi Komiya more than expected).

Fields of papers citing papers by Kazutoshi Komiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazutoshi Komiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazutoshi Komiya. The network helps show where Kazutoshi Komiya may publish in the future.

Co-authorship network of co-authors of Kazutoshi Komiya

This figure shows the co-authorship network connecting the top 25 collaborators of Kazutoshi Komiya. A scholar is included among the top collaborators of Kazutoshi Komiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazutoshi Komiya. Kazutoshi Komiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kashiwada, Tomomi, et al.. (2019). Nab-paclitaxel plus ramucirumab combination therapy as second-line with advanced gastric cancer:Retrospective study. Annals of Oncology. 30. vi140–vi140. 1 indexed citations
2.
Kawano, Yuko, T. Sasaki, Hiroyuki Yamaguchi, et al.. (2018). Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer. Lung Cancer. 125. 136–141. 16 indexed citations
3.
Takahashi, Koichiro, et al.. (2018). Sjögren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis. SHILAP Revista de lepidopterología. 2018. 1–5. 5 indexed citations
4.
Komiya, Kazutoshi, Chiho Nakashima, Tomomi Nakamura, et al.. (2018). Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy. Anticancer Research. 38(6). 3559–3566. 9 indexed citations
5.
Komiya, Kazutoshi, Chiho Nakashima, Tomomi Nakamura, et al.. (2018). A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy. Annals of Translational Medicine. 6(23). 464–464. 6 indexed citations
6.
Tashiro, Hiroki, Koichiro Takahashi, Kazutoshi Komiya, et al.. (2018). Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis. Respiratory Investigation. 56(2). 166–172. 11 indexed citations
7.
Nakashima, Chiho, Akemi Sato, Junichi Kato, et al.. (2018). Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments. Oncotarget. 9(38). 25181–25192. 23 indexed citations
8.
Nakamura, Tomomi, Chiho Nakashima, Kazutoshi Komiya, et al.. (2018). Mechanisms of acquired resistance to afatinib clarified with liquid biopsy. PLoS ONE. 13(12). e0209384–e0209384. 31 indexed citations
9.
Takahashi, Koichiro, et al.. (2017). Successful treatment of pulmonary nocardiosis with fluoroquinolone in bronchial asthma and bronchiectasis. Respirology Case Reports. 5(3). e00229–e00229. 11 indexed citations
10.
Sueoka‐Aragane, Naoko, Kentaro Iwanaga, Kazutoshi Komiya, et al.. (2017). Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer. Medical Oncology. 34(12). 195–195. 9 indexed citations
11.
Nakamura, Tomomi, Naomi Watanabe, Akemi Sato, et al.. (2017). Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge. Oncology Letters. 13(6). 4939–4946. 1 indexed citations
12.
Komiya, Kazutoshi, Tomomi Nakamura, Chiho Nakashima, et al.. (2016). SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer. OncoTargets and Therapy. Volume 9. 6663–6668. 43 indexed citations
13.
Tashiro, Hiroki, Koichiro Takahashi, Tomomi Nakamura, et al.. (2016). Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report. Journal of Medical Case Reports. 10(1). 113–113. 12 indexed citations
14.
Sakata, Shinya, Sho Saeki, Isamu Okamoto, et al.. (2016). Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301. Lung Cancer. 99. 41–45. 22 indexed citations
15.
Kashiwada, Tomomi, Kazutoshi Komiya, Takahiko Nakazono, et al.. (2015). A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma. Annals of Oncology. 26. vii112–vii112. 1 indexed citations
16.
Kitahara, Kenji, et al.. (2013). Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy. World Journal of Surgical Oncology. 11(1). 167–167. 5 indexed citations
17.
Nakamura, Tomomi, Naoko Sueoka‐Aragane, Kentaro Iwanaga, et al.. (2011). A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA. Journal of Thoracic Oncology. 6(10). 1639–1648. 61 indexed citations
18.
Komiya, Kazutoshi, Naoko Sueoka‐Aragane, Akemi Sato, et al.. (2009). Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. Journal of Cancer Research and Clinical Oncology. 136(3). 465–473. 30 indexed citations
19.
Sueoka‐Aragane, Naoko, Kazue Imai, Kazutoshi Komiya, et al.. (2008). Exon 19 of EGFR mutation in relation to the CA‐repeat polymorphism in intron 1. Cancer Science. 99(6). 1180–1187. 13 indexed citations
20.
Sueoka, Naoko, Akemi Sato, Hidetaka Eguchi, et al.. (2006). Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients. Journal of Cancer Research and Clinical Oncology. 133(2). 93–102. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moon Young Choi Breakdown of academic impact, for papers by Ming Ouyang Breakdown of academic impact, for papers by Joonho Shim Breakdown of academic impact, for papers by Thomas Boulet Breakdown of academic impact, for papers by Shaohong Huang Breakdown of academic impact, for papers by Andrew A. Davis Breakdown of academic impact, for papers by Xia Zhu Breakdown of academic impact, for papers by Yingjie Wang Breakdown of academic impact, for papers by Yoshiaki Nagai
Rankless by CCL
2026